top of page
  • Facebook
  • Instagram
  • YouTube

Weight Loss Drugs Under FDA Warning: Know How They May Affect Your Eyes

Weight Loss Drugs Under FDA Warning

Weight loss medications have become increasingly popular for managing obesity, improving blood sugar levels, and supporting metabolic health.

Medicines containing semaglutide and other GLP-1 receptor agonists have gained attention because of their effectiveness in helping people lose weight. However, recent safety concerns have raised an important question: Can weight loss drugs affect your eyesight?


The US Food and Drug Administration (FDA) has highlighted concerns about a rare but potentially serious eye condition associated with certain weight loss medications. One condition receiving particular attention is Non-Arteritic Anterior Ischemic Optic Neuropathy (NAION), sometimes described as an eye stroke because it involves reduced blood flow to the optic nerve.


Although these medications can offer significant health benefits when prescribed appropriately, understanding their possible side effects is essential. People taking weight loss injections or tablets should be aware of unusual vision changes and know when to seek medical attention.


At ADEH, we believe that awareness, timely diagnosis, and appropriate eye care are important for protecting long-term vision. In this blog, we explain the potential connection between weight loss medications and eye health, warning signs to recognise, and when you should consult an eye specialist.


What Has the FDA Warned About?


On November 9, 2026, the US Food and Drug Administration (FDA) announced that manufacturers of GLP-1 receptor agonist medications must update their product labels to include information about the potential increased risk of NAION.


The warning applies to several medications used for diabetes management and weight reduction, including:


  • Semaglutide: Ozempic, Wegovy and Rybelsus

  • Liraglutide: Saxenda and Victoza

  • Dulaglutide: Trulicity

  • Tirzepatide: Mounjaro and Zepbound

  • Other GLP-1-based medications: Including certain combination treatments.

These medicines work by mimicking the natural GLP-1 hormone, which helps regulate blood sugar, appetite, and food intake.


The FDA reviewed clinical trial data, observational studies, and safety reports before announcing the warning. Its analysis of 126 clinical trials found approximately 6.4 NAION cases per 100,000 person-years among GLP-1 users, compared with 3.8 cases per 100,000 person-years in the comparison group.


It is important to understand that this is a potential safety risk, not proof that everyone taking these medications will experience vision problems. The condition remains rare, but its consequences can be serious.


What Is NAION (Eye Stroke)?


Non-Arteritic Anterior Ischemic Optic Neuropathy, commonly known as NAION, is an eye condition that occurs when the blood supply to the optic nerve is reduced.

The optic nerve carries visual information from the eye to the brain. When its blood supply becomes inadequate, the nerve can become damaged, resulting in sudden vision loss.


NAION is sometimes called an eye stroke because of its association with reduced blood flow. However, it is different from a stroke affecting the brain.

One of the most concerning features of NAION is that it usually develops suddenly and without pain. Some people first notice a change in their vision when they wake up in the morning.


Unfortunately, vision loss caused by NAION can be permanent. Early medical evaluation is essential to identify the condition, assess the affected eye, and protect overall eye health.


How Can Weight Loss Drugs Potentially Affect Your Eyes?


GLP-1 medications are widely prescribed because of their benefits in managing obesity and type 2 diabetes. However, emerging safety evidence has raised concerns about their possible relationship with optic nerve damage.

Here are some important ways these medications may be associated with eye health concerns.


1. Reduced Blood Supply to the Optic Nerve

The main concern highlighted by the FDA is the potential association between GLP-1 medications and NAION.


The optic nerve requires a continuous supply of oxygen and nutrients through blood circulation. When this supply is interrupted or reduced, the nerve may become damaged.


Researchers are still investigating the exact biological mechanism behind the potential association between GLP-1 medications and NAION.


People with diabetes, high blood pressure, sleep apnoea, kidney disease, or other vascular risk factors may already have an increased risk of developing this condition.


2. Sudden or Painless Vision Loss

One of the most important warning signs of NAION is sudden vision loss in one eye.


Unlike some other eye conditions, NAION generally does not cause pain or noticeable irritation. This can make it difficult for people to recognise the seriousness of the problem.


A person may initially experience blurred vision, missing areas in their visual field, or reduced clarity.


If these symptoms appear while taking weight loss medication, immediate medical assessment is necessary.


3. Changes in Vision in People With Diabetes

Some GLP-1 medications are also prescribed to people with type 2 diabetes.

People with diabetes are already at risk of diabetic retinopathy, a condition that damages the blood vessels in the retina.


In some patients, rapid improvement in blood sugar levels during treatment can temporarily worsen existing diabetic retinopathy. This is a recognised concern with semaglutide treatment in people with diabetes.


This is different from NAION, which affects the optic nerve rather than the retina.

People with diabetes should maintain regular eye examinations and inform their healthcare providers about changes in their blood sugar levels and vision.


4. Increased Concern in People With Existing Eye or Vascular Problems

Individuals with certain health conditions may require additional attention when considering GLP-1 medications.


These include people with:


  • Previous NAION in either eye.

  • Diabetes or poorly controlled blood sugar.

  • High blood pressure.

  • Obstructive sleep apnoea.

  • Kidney disease.

  • Anaemia.

  • A history of vascular problems.

  • Smoking habits.

Having these risk factors does not mean that a person will develop NAION. However, discussing their medical history with the prescribing doctor is important before starting treatment.


7 Warning Signs of Eye Problems You Should Never Ignore


Recognising changes in eyesight early can help prevent delays in medical assessment.


If you are taking weight loss medication, pay attention to the following symptoms:

  1. Sudden blurred vision: A sudden reduction in clarity in one eye should never be ignored.


  2. Partial vision loss: Missing portions of your visual field may indicate an optic nerve problem.

  3. Dark or hazy spots: New blind spots or shadows in your vision require prompt examination.

  4. Distorted colour perception: Colours may appear less bright or different in the affected eye.

  5. Reduced central vision: You may find it difficult to recognise faces, read, or focus on objects.

  6. Tunnel vision: Your peripheral vision may become restricted, making it difficult to see objects around you.

  7. Sudden vision changes after waking up: Some people with NAION first notice symptoms in the morning.

Medical emergency

Sudden, painless vision loss in one eye requires immediate ophthalmic evaluation. Do not wait for the symptoms to improve on their own.

Who May Be at Higher Risk of NAION?

NAION can affect different individuals, but certain medical and lifestyle factors may increase the likelihood of developing the condition.

Some recognised risk factors include:

Risk factor

How it may affect eye health

Diabetes

Can damage blood vessels and affect circulation.

High blood pressure

May contribute to vascular damage.

Sleep apnoea

Can cause repeated drops in oxygen levels during sleep.

Smoking

Can negatively affect blood circulation.

Kidney disease

May be associated with vascular and metabolic complications.

Anaemia

Can reduce the oxygen-carrying capacity of blood.

Previous NAION

Increases concern about involvement of the other eye.

People with these conditions should discuss their individual risks with their treating doctor before beginning or continuing GLP-1 medication.

How Is NAION Diagnosed?


An ophthalmologist performs a detailed eye examination to identify possible optic nerve damage and rule out other causes of sudden vision loss.


Depending on the patient's symptoms and medical history, the evaluation may include:

1. Visual Acuity Test

This test measures how clearly a person can see objects at different distances.

2. Pupil Examination

The doctor checks how the pupils respond to light. An abnormal response may indicate optic nerve dysfunction.

3. Dilated Fundus Examination

Eye drops are used to widen the pupils so the ophthalmologist can examine the optic nerve and retina.

4. Optical Coherence Tomography (OCT)

OCT provides detailed images of the retina and optic nerve head, helping doctors identify structural changes.

5. Visual Field Testing

This examination checks whether a person has lost any part of their central or peripheral vision.


6. Additional Medical Investigations

Depending on the findings, the doctor may recommend blood pressure assessment, blood tests, or other investigations to identify associated risk factors and rule out other conditions.

Early diagnosis is important because some causes of sudden vision loss require urgent treatment.


Can Vision Loss Caused by NAION Be Reversed?


Unfortunately, there is currently no proven treatment that reliably restores vision lost due to NAION.

Some patients may experience partial improvement over time, but many continue to have permanent visual impairment.

Treatment mainly focuses on:

  • Identifying and managing underlying health conditions.

  • Controlling blood pressure and blood sugar appropriately.

  • Evaluating sleep apnoea and other vascular risk factors.

  • Monitoring the unaffected eye.

  • Reviewing medications with the prescribing doctor.

  • Providing visual rehabilitation when necessary.

The primary goal is to prevent further complications and protect the remaining vision.

What Should You Do If You Are Taking Weight Loss Injections?


If you are currently using medications such as Ozempic, Wegovy, Saxenda, or Mounjaro, there is no need to panic. However, being aware of potential side effects is important.


Follow these precautions:

1. Never Take Weight Loss Medication Without Medical Advice

These medicines should only be used when prescribed by a qualified healthcare professional. Avoid self-medication and unverified weight loss injections.

2. Do Not Ignore Sudden Vision Changes

If you experience sudden blurred vision, blind spots, or vision loss, seek immediate medical attention.

3. Do Not Stop Medication Without Consulting Your Doctor

Stopping a prescribed medication without medical advice may affect your diabetes or weight-management plan. Discuss the benefits and risks with the prescribing doctor. If NAION is suspected or confirmed, an urgent review of the medication is necessary.

4. Manage Existing Health Conditions

Keep your blood pressure, blood sugar, and other medical conditions under appropriate control.

5. Maintain Regular Eye Examinations

People with diabetes or existing eye conditions should follow their ophthalmologist's recommended examination schedule.

6. Inform Your Eye Doctor About All Medications

Always share details of your weight loss injections, diabetes medicines, supplements, and other prescribed treatments during an eye examination.

Should You Stop Taking Ozempic or Other GLP-1 Weight Loss Drugs?


The FDA warning does not mean that everyone should discontinue these medications.

GLP-1 medications can provide important benefits for people managing obesity and type 2 diabetes. Their potential benefits and risks should be evaluated individually.


The American Academy of Ophthalmology also advises patients not to stop GLP-1 medications independently because of the warning.

If you experience sudden vision changes, contact an ophthalmologist immediately and inform the doctor who prescribed your medication.

If NAION is confirmed, the treating ophthalmologist and prescribing doctor should work together to assess whether the medication should be discontinued. The FDA advises considering discontinuation unless the benefits clearly outweigh the risks.


The decision should always be based on an individual medical assessment.


When Should You Visit an Eye Specialist?


You should seek immediate eye care if you notice:


  • Sudden loss of vision in one eye.

  • New blind spots or missing areas in your visual field.

  • Sudden changes in colour perception.

  • Rapidly worsening eyesight.

  • Sudden blurred or hazy vision.

Do not wait for a routine appointment if these symptoms develop.

Even if there is no pain, sudden vision loss can indicate a serious eye condition that requires urgent evaluation.

How ADEH Supports Your Eye Health


At ADEH (Arunodaya Deseret Eye Hospital), eye health awareness and timely ophthalmic evaluation are important parts of comprehensive vision care.

The hospital's ophthalmology team includes experienced eye specialists with expertise in different areas of eye care.

For patients experiencing unexplained vision changes, an appropriate ophthalmic assessment can help identify whether the problem involves the retina, optic nerve, or another part of the visual system.

The relevant specialists in the ADEH team include:


  • Dr. Arun Sethi: Eye Surgeon, Cataract and Refractive Surgeon. Qualifications: MBBS, DOMS, MS, FIOL (USA).

  • Dr. Vaibhav Sethi: Vitreo-Retina Specialist. Qualifications: MBBS, DNB, FICO (UK), FLVPEI. He completed postgraduate training at Aravind Eye Hospital, Tirunelveli, and a long-term fellowship at L.V. Prasad Eye Institute, Hyderabad.

Dr. Vaibhav Sethi's vitreoretinal expertise is relevant to evaluating retinal causes of visual symptoms. However, NAION specifically affects the optic nerve and requires appropriate optic nerve assessment.

If you are taking weight loss medication and notice unusual changes in your vision, do not delay seeking professional eye care.


Conclusion

Weight loss medications have helped many people manage obesity and diabetes, but recent FDA safety updates highlight the importance of understanding their potential risks to eye health.

The possible association between GLP-1 medications and NAION deserves attention because this rare condition can cause sudden and sometimes permanent vision loss.

However, patients should not panic or stop their prescribed medications independently. Understanding the warning signs, managing existing medical conditions, and seeking timely ophthalmic evaluation can help support better eye health.


At ADEH, we encourage individuals to take sudden vision changes seriously and consult an eye specialist without delay. Protecting your eyesight begins with awareness and timely medical attention.

Frequently Asked Questions (FAQs)

1. Can weight loss injections cause permanent vision loss?

Certain GLP-1 medications have been associated with a potential increased risk of NAION, a rare condition that can cause permanent vision loss. However, the risk is low and does not affect everyone using these medications.

2. Which weight loss medications are associated with NAION?

The FDA warning covers GLP-1 receptor agonist medications, including semaglutide, liraglutide, and other medicines in this drug class. Examples include Ozempic, Wegovy, Rybelsus, and Saxenda.

3. What is an eye stroke?

An eye stroke, in this context, refers to NAION. It occurs when blood flow to the optic nerve is reduced, potentially causing sudden and painless vision loss in one eye.

4. Is NAION painful?

No. NAION typically causes sudden vision loss without pain. Some people notice the problem immediately after waking up.

5. Should diabetic patients taking semaglutide get regular eye check-ups?

Yes. People with diabetes should follow regular diabetic eye screening schedules. This helps identify diabetic retinopathy and other eye complications at an early stage.

6. Can vision recover after NAION?

Some patients may experience partial improvement, but vision loss can be permanent. There is currently no proven treatment that reliably restores vision lost due to NAION.

7. When should I consult an ophthalmologist?

Consult an ophthalmologist immediately if you experience sudden blurred vision, blind spots, colour distortion, or vision loss in one eye. Do not wait for symptoms to disappear.

Comments


WhatsApp
bottom of page